Exosomes are secreted membrane vesicles that share structural and biochemical characteristics with intraluminal vesicles of multivesicular endosomes (MVEs). Exosomes could be involved in intercellular communication and in the pathogenesis of infectious and degenerative diseases. The molecular mechanisms of exosome biogenesis and secretion are, however, poorly understood. Using an RNA interference (RNAi) screen, we identified five Rab GTPases that promote exosome secretion in HeLa cells. Among these, Rab27a and Rab27b were found to function in MVE docking at the plasma membrane. The size of MVEs was strongly increased by Rab27a silencing, whereas MVEs were redistributed towards the perinuclear region upon Rab27b silencing. Thus, the two Rab27 isoforms have different roles in the exosomal pathway. In addition, silencing two known Rab27 effectors, Slp4 (also known as SYTL4, synaptotagmin-like 4) and Slac2b (also known as EXPH5, exophilin 5), inhibited exosome secretion and phenocopied silencing of Rab27a and Rab27b, respectively. Our results therefore strengthen the link between MVEs and exosomes, and introduce ways of manipulating exosome secretion in vivo.
. These nanometre-sized vesicles have a similar membrane orientation as the plasma membrane, and a canonical protein composition, mostly including proteins from the endocytic system, the plasma membrane and the cytosol. In addition, exosomes also contain proteins specific to the cell type from which they originate and that are probably important for their extracellular functions. Based on in vitro studies, it has been proposed that exosomes could participate in the induction of immune responses [5] [6] [7] , in the dissemination of viruses or prions 8, 9 , in the pathogenesis of neurodegenerative diseases 10 and in mediating communication between tumour cells and their microenvironment [11] [12] [13] . However, it has not been conclusively demonstrated that in vivo exosome secretion has a role in any physiological process due to the inability to specifically inhibit or increase it. Indeed, the molecular mechanisms of exosome secretion are not completely understood.
Evidence collected during the last 20 years suggests that, in most cell types, exosomes correspond to secreted intraluminal vesicles of MVEs 4 . Intraluminal vesicles are formed by inward budding of the limiting membrane of MVEs into the lumen of these endosomes 14 . Observations, using electron microscopy, of fusion profiles between MVEs and the plasma membrane and the consequent release of intraluminal vesicles as exosomes has so far been the strongest evidence for the endosomal origin of exosomes 5, 6, 15 . Nevertheless, in some cell types, such as T lymphocytes, exosomes bud at the plasma membrane from endosome-like domains 16 . Therefore, identification of molecules that control the intracellular trafficking of MVEs and their fusion with the plasma membrane will increase our understanding of exosome secretion.
Most intracellular transport pathways are controlled by conserved families of cytosolic proteins, including the Rab family of small GTPases. Rab proteins control different steps of vesicular trafficking, including budding, motility and docking and fusion of different vesicular transport intermediates to acceptor membranes 17 . Almost 70 Rab proteins and Rab-like proteins have been identified in humans 18 , and a wide range of specific effector proteins that execute their diverse roles has also been identified 19 
.
Here we analyse the possible functions of Rab proteins in exosome production or secretion by the human HeLa cells, using a short hairpin RNA (shRNA)-based screen targeting human Rab genes. We observed that knocking down five Rab proteins (Rab2b, Rab9a, Rab5a, Rab27a and Rab27b) inhibited exosome secretion without major modifications in the secretion of soluble proteins through the regular secretory pathway. The roles of Rab27a and Rab27b were analysed further, and we demonstrated a common function in MVE docking to the plasma membrane, but also different and non-redundant roles in the MVE pathway. In addition, silencing of two known Rab27 effectors, Slp4 and Slac2b, phenocopied silencing of Rab27a and Rab27b, respectively, suggesting a preferential interaction between these proteins for exosome secretion.
RESULTS

Semi-quantitative detection of exosomes in cell culture supernatants
To screen for molecules specifically involved in exosome secretion, we developed a semi-quantitative fluorescence-activated cell scanning (FACS)-based assay that allowed simultaneous detection of exosomes and proteins secreted through the classical secretory pathway in small volumes of cell culture supernatants. The HeLa B6H4 tumour cell line, which stably expresses the transactivator CIITA (an activator of the MHC class II family genes, including HLA-DR) and a secreted form of chicken ovalbumin (OVA), was used. These cells secrete HLA-DR-positive exosomes and soluble OVA (through the classical secretory pathway), allowing differentiation of both pathways. Exosomes present in cell culture supernatants were captured onto beads coated with antibodies to CD63, a tetraspanin strongly enriched in late endosomes and exosomes 20 , and were detected by FACS after staining with anti-HLA-DR and anti-CD81 fluorescent antibodies (CD81 is another tetraspanin abundant on exosomes) 5, 20 , or annexin V (which binds to the phosphatidylserine present at the surface of exosomes; Fig. 1a ) 21 . Membrane vesicles with a diameter ranging from 50 to 100 nm and with the typical cup-shaped morphology of exosomes were detected on the surface of the beads by electron microscopy (Fig. 1b) . Exosome detection was dependent on the number of exosome-secreting cells present in the wells (Fig. 1c, d) , with a sensitivity threshold of 75,000 cells per well. When supernatants from apoptotic cells (which secrete apoptotic blebs but not exosomes) Exo  OVA  mRNA  Exo  OVA  mRNA   Exo  OVA  mRNA  Exo  OVA  mRNA   0   25   50   75   100   125   0   25   50   75   100   125   sh1  sh2  sh3  sh4  sh1  sh2  sh3  sh4  sh1  sh2  sh3  sh4  sh1  sh2  sh3  sh4  sh1  sh2  sh3  sh4  sh1  sh2  sh3  sh4  sh1  sh2  sh3  sh4  sh5  sh1  sh2  sh3  sh4  sh5  sh1  sh2  sh3  sh4  sh5   sh1  sh2  sh3  sh4  sh5  sh1  sh2  sh3  sh4  sh5  sh1  sh2  sh3  sh4  sh5  sh1  sh2  sh3  sh4  sh5  sh1  sh2  sh3  sh4  sh5  sh1  sh2  sh3  sh4  sh5  sh1  sh2  sh3  sh1  sh2  sh3  sh1  sh2  sh3   sh1  sh2  sh3  sh4  sh1  sh2  sh3  sh4  sh1  sh2  sh3  sh4  sh1  sh2  sh3  sh4  sh1  sh2  sh3  sh4  sh1  sh2  sh3  sh4  sh1  sh2  sh3  sh4  sh1  sh2  sh3 sh4 targeting Rab family members that were selected as candidate hits because at least two shRNAs significantly affected exosome secretion without affecting OVA secretion. Data are mean ± s.d. of measurements performed in five (Rab2b, Rab9a and Rab5a) or nine (Rab27a and Rab27b) different wells present in independent plates.(d) Exosome secretion by control and Rab27a-or Rab27b-knockdown cells was also evaluated by detection of exposed phosphatidylserine with annexin V. Data are mean ± s.d. of measurements performed in three independent wells. Arrows in c and d indicate shRNAs that were chosen for further characterization. Asterisks indicate statistically significant differences from the control. *P < 0.05, **P < 0.01, ***P < 0.001 (one-way ANOVA followed by Tukey's post test). Exo, exosome.
were used, the FACS signals were significantly lower than those obtained from supernatants of living cells (Fig. 1e) . Secretion of soluble OVA in cell culture supernatants was detected using beads coated with anti-OVA antibodies and stained with a fluorescent anti-OVA antibody ( Supplementary Information, Fig. S1 ). This methodology allowed the quantitative detection of OVA from live cells, with a sensitivity threshold of 30,000 cells per well.
This FACS-based assay thus allowed simultaneous quantification of CD63/CD81/HLA-DR/phosphatidylserine-positive membrane vesicles (corresponding to exosomes) and of OVA, produced by living cells, in very small volumes of culture supernatants.
The role of Rab GTPase family members in exosome secretion
The effects of various shRNAs on exosome secretion were analysed by screening a lentiviral shRNA library targeting 59 members of the Rab GTPase family, using the methodology described above. Cells expressing scrambled shRNA were used as controls for both OVA and exosome secretion pathways (Fig. 2a) . Genes for which at least two different shRNAs induced a significant modification in the secretion of exosomes, but not of OVA, were selected for two additional rounds of validation. Some examples of Rab proteins that did not fulfil the selection criteria are shown in Fig. 2b . Silencing of Rab6a inhibited the secretion of OVA but did not affect exosome secretion, whereas inhibition of Rab7 or Rab11a did not significantly modify either exosome or OVA secretion. In contrast, five Rab proteins whose inhibition by shRNA resulted in decreased exosome secretion in at least five independent wells, and for which most shRNA concomitantly modified the phenotype and the mRNA expression level (as determined by quantitiative PCR, qPCR), were finally selected ( Fig. 2c) : Rab2b, Rab5a, Rab9a, Rab27a and Rab27b. Most of these Rab proteins have been previously associated with endocytic functions, in agreement with the postulated endosomal origin of exosomes.
We chose to further analyse the mechanism of exosome secretion inhibition caused by silencing Rab27a and Rab27b, two homologous Rab proteins (71% amino-acid identity) 23 encoded by different genes and associated with lysosome-related organelles. To ensure that Rab27 silencing affects total exosome secretion rather than any specific exosome-associated protein, we performed annexin V staining of phosphatidylserine . Scale bars, 250 nm. Right, the surface area of individual CD63-positive multivesicular compartments on randomly taken electron micrographs was measured. Asterisks indicate statistically significant differences. *P < 0.05, **P < 0.01, ***P < 0.001 (one-way ANOVA followed by Tukey's post test). KD, knockdown.
on exosomes captured by CD63-coated beads (Fig. 2d) . Silencing of both Rab27a and Rab27b decreased annexin V staining, thus showing a general decrease of secretion of exosome-associated lipids.
Rab27a and Rab27b silencing inhibits exosome secretion without modifying exosome protein composition
Inhibition of exosome secretion in cells knocked down for Rab27a and Rab27b was confirmed by standard exosome purification techniques 24 . First, cells transfected with shRNA 3 for RAB27A or shRNA 1 for RAB27B were amplified to produce a large volume of supernatant. Expression of these genes was specifically and significantly downregulated in these cells ( Supplementary Information, Fig. S2a ). Exosomes were purified from cell supernatant by ultracentrifugation 24 (at 100,000g). The total amount of secreted exosomes, determined by measuring the total amount of protein in a pellet (Fig. 3a) or by the FACS-based assay ( Supplementary  Information, Fig. S2b ), was significantly reduced in both knockdown cells when compared with control cells.
Consistent with these findings, a reduction in the signals of several exosome markers (HLA-DR, CD63, Tsg101 and Hsc70) was observed by western blotting of exosomes purified from the supernatant of the same number of Rab27a-knockdown or Rab27b-knockdown secreting cells when compared with control cells ( Fig. 3b ; Supplementary Information, 
FigS6a
). Nevertheless, all markers were detected in exosomes from knockdown cells when similar amounts of exosomal proteins where analysed ( Fig. 3c ; Supplementary Information, Fig.S6b ). In addition, electron microscopy showed that exosomes secreted by Rab27a-and Rab27b-knockdown cells were identical in size and morphology to exosomes produced by control cells (Fig. 3d ). These data show that silencing of either Rab27a or Rab27b reduces the amount of exosomes released in the cell culture supernatant, but does not modify exosome protein content or morphology.
Different phenotypes of MVEs are observed in Rab27a-and Rab27b-knockdown cells
To gain further insight into the mechanism responsible for the reduced exosome secretion in Rab27a-or Rab27b-knockdown cells, the subcellular distribution and the morphology of MVEs were investigated using CD63 as a marker. We first observed, by FACS analysis, that the proportion of intracellular to surface CD63 was increased in Rab27a-, but not Rab27b-, knockdown cells when compared with control cells (Fig. 4a) . Thus, in the absence of Rab27a, CD63 accumulates in internal compartments, whereas the absence of Rab27b does not induce such behaviour.
The subcellular distribution of CD63 was then analysed by immunofluorescence imaging (Fig. 4b, c) . In control and Rab27a-knockdown cells, CD63-positive MVEs appeared to be homogenously distributed throughout the cell, but their size was significantly increased upon Rab27a silencing (Fig. 4b , upper and middle panels; Fig. 4c ). In sharp contrast, Rab27b-knockdown cells showed a characteristic asymmetrical perinuclear accumulation of CD63-positive organelles, but without significant alteration of the size of these organelles, compared with control cells (Fig. 4b, lower panel, Fig. 4c ). Consistent with these findings, electron microscopy analysis showed that MVEs from Rab27a-knockdown cells were significantly larger (Fig. 4d ) than those from control cells, whereas in Rab27b-knockdown cells MVEs were smaller (Fig. 4d ) and showed a clustered distribution (data not shown). Thus, although silencing of either Rab27a or Rab27b impairs exosome secretion, the induction of different changes in the size and distribution of CD63-positive MVEs suggests that these proteins have different roles in the pathway.
Rab27a and Rab27b have different subcellular localizations
We thus investigated whether these two proteins could function in different compartments by analysing their respective subcellular localizations. GFP-tagged versions of both Rab27a and Rab27b presented a doughnut-like pattern surrounding CD63-positive compartments (Fig. 5a ). However, most Rab27b, but not Rab27a, was mainly concentrated in a perinuclear area labelled by the Golgi-associated proteins Rab6 (Fig. 5a ) and TGN46 (data not shown). Consistent with this, electron microscopic observation showed that although both Rab27a and Rab27b were associated with the limiting membrane of MVEs, Rab27b was also observed in the membrane of Golgi stacks and in vesicles located in the trans-Golgi network (TGN) area (Fig. 5b) .
When mCherry-Rab27a and GFP-Rab27b were expressed simultaneously in HeLa cells, both Rab27a and Rab27b were partially associated with CD63-positive compartments (Fig. 5c ), but Rab27b was predominantly in the perinuclear area and was partially colocalized with TGN46 (data not shown). Four groups of CD63-positive organelles could be identified based on their association with the Rab27 isoforms: most organelles were Rab27a-and b-negative, about 1/5 were Rab27a-positive and b-negative and less than 10% were either Rab27a-and b-positive or Rab27a-negative and b-positive. However, the proportion of Rab27-positive MVEs was increased in the subplasmalemmal region ( Supplementary Information, Fig. S3 ).
Rab27a and Rab27b therefore have different subcellular distributions: Rab27b predominantly presents an asymmetrical perinuclear distribution in the TGN area and a minor localization to CD63-positive compartments, whereas Rab27a is preferentially associated with CD63-positive MVEs.
Rab27a or Rab27b silencing reduces MVE docking to the plasma membrane
To further analyse exosome secretion, we used total internal reflection fluorescence (TIRF) microscopy to image MVEs in the subplasmalemmal region of live cells ( Fig. 6; Supplementary Information, Fig. S3 and Movies 1-3). In this region, around 30% and 40% of CD63-positive vesicles were labelled with GFP-Rab27b and GFP-Rab27a, respectively ( Supplementary Information, Fig. S3a) , supporting a possible role of both Rab27 isoforms in MVE exocytosis. Rab27b silencing significantly lowered MVE density (Fig. 6a ), in agreement with the perinuclear relocalization of MVEs observed by epifluorescence microscopy (Fig. 4b) . In addition, in Rab27a-and Ra27b-knockdown cells, MVEs were significantly less present near the borders of the cell footprint ( Supplementary  Information, Fig. S3b ), suggesting that Rab27a and Rab27b promote MVE distribution to the cell periphery. The movements of MVEs were then analysed by tracking individual trajectories 25 ( Supplementary Information, Movies 1-3) . The diffusion coefficient D xy , an index of mobility, was calculated along trajectories using a rolling analysis window 25 . D xy values were higher in Rab27a-or Rab27b-knockdown cells than in control cells (P < 0.0001), and in Rab27b-than in Rab27a-knockdown cells (P = 0.006; Fig. 6b ). Fewer vesicles had very low D xy values in Rab27a-or Rab27b-knockdown cells, suggesting that both may participate in MVE attachment (docking) to the plasma membrane, a process that restricts vesicle motion [25] [26] [27] . To set a threshold value below which vesicles could be considered immobile, we plotted the distribution of instantaneous D xy values ( Supplementary Information, Fig. S3c) . A major peak comprising the lowest values was centered around 10 -4 μm 2 s -1 (that is, the mean D xy of immobilized beads on our setup) 26 . Vesicles presenting a D xy less than three times this value were considered immobile. Using this criterion, we categorized D xy values computed on entire trajectories and found that the percentage of docked structures was significantly lowered by Rab27a or Rab27b silencing (Fig. 6c) . Moreover, 82% of the enlarged MVEs observed upon Rab27a silencing (Fig. 4b) showed a mean D xy > 3 × 10 -4 μm 2 s -1 (50 structures from 5 cells) and were thus not docked. To distinguish true vesicle docking from other processes, we measured the duration of immobilization events along trajectories. Rab27a or Rab27b silencing reduced the percentage of vesicles that were always immobile and increased the percentage of vesicles never immobile (Fig. 6d) . Survival curves of immobilization times were best fitted with two exponentials, indicating the existence of two different processes (Fig. 6e) . The short-lasting component may reflect transient tethering to the plasma membrane or phases of slow diffusion. We considered longlasting immobilization to reflect MVE docking. Using this refined criterion of docking, we conclude that Rab27a or Rab27b silencing reduced both the number (0.25 and 0.28 docking events per trajectory in Rab27a-and Rab27b-knockdown cells, respectively, compared with 0.44 in control cells) and the characteristic time (10.1 and 9.3 s in Rab27a-and Rab27b-knockdown cells, respectively, compared with 15.5 s in control cells) of docking events. Altogether, these analyses show that Rab27a and Rab27b promote the occurrence and stability of MVE docking.
Another alteration was observed in Rab27b-knockdown cells. The proportion (39 ± 3% versus 29 ± 3% in control cells) and velocity (Fig. 6f ) of vesicles moving rapidly along linear axes (a characteristic of microtubule-based motion) 26 were increased in Rab27b-knockdown (but not in Rab27a-knockdown) cells, compared with control cells. This behaviour accounted for the increased proportion of structures with high mean D xy (> 20 × 10 -4 μm 2 s -1 ; Fig. 6c ) observed in Rab27b-knockdown cells. Therefore, Rab27b also negatively regulates longrange movements of MVEs. Supplementary Information, Table 1) . Their genes were then silenced with specific shRNAs, and exosomes and OVA in cell culture supernatants were quantified using the FACS-based assay.
Slp4 and Slac2b are two Rab27 effectors involved in exosome production
Silencing of EXPH5 (gene encoding Slac2b), SYTL4 (gene encoding Slp4) or UNC13D (gene encoding Munc13-4) significantly reduced exosome secretion, with at least 2 of the 4-5 shRNAs that targeted each gene (Fig. 7a) . In cells transduced with shRNAs against SYTL4 and EXPH5, the level of exosome secretion reflected the level of mRNA expression (Fig. 7b) . In contrast, in cells transduced with UNC13D shRNA, although shRNAs 1, 2 and 3 decreased both exosome secretion and mRNA levels, shRNAs 4 and 5 strongly inhibited mRNA expression without affecting exosome secretion (Fig. 7a, b) , suggesting off-target effects of the shRNA. Consequently, only Slac2b and Slp4 were chosen for further analysis, although a role of Munc13-4 in exosome secretion cannot be ruled out. In addition to reducing exosome secretion, knock down of the effectors increased OVA secretion (Fig. 7a) , suggesting that they also have Rab27-independent roles in the conventional secretion pathway.
Large-scale cultures of cells expressing lentiviruses 3 (EXPH5 shRNA) or 3 (SYTL4 shRNA) were prepared. Specific decrease of Slp4 at the protein level was confirmed by immunoblotting ( Fig. 7c ; Supplementary  Information, FigS6c ), but we could not specifically detect Slac2b by western blotting of B6H4 cell lysates, probably due to the low level of expression. Exosomes secreted by the same amount of cells were purified from cell culture supernatants and analysed by western blotting ( Fig. 7d; Supplementary Information, FigS6e ): a significant reduction in the amount of CD63, HLA-DR and Tsg101 secreted in exosomes was observed in Slp4-and Slac2b-knockdown cells. These results show that two Rab27 effectors, Slp4 and Slac2b, are positive regulators of exosome secretion in HeLa B6H4 cells.
Slp4 and Slac2b-knockdown cells are phenocopies of Rab27a and Rab27b-knockdown cells, respectively
The distribution and morphology of CD63-positive compartments was then studied in Slac2b-and Slp4-knockdown cells. In Slp4-knockdown cells, an intracellular accumulation of CD63 was observed both by FACS (Fig. 7e) and by immunofluorescence (Fig. 7f, left and middle panels), resembling the phenotype observed in Rab27a-knockdown cells (Fig. 4a) . In contrast, FACS analysis of Slac2b-knockdown cells did not show an accumulation of CD63 either at the cell surface or intracellularly, but showed an asymmetrical perinuclear accumulation of CD63-positive vesicles of normal size, mimicking the phenotype observed in Rab27b-knockdown cells (Fig. 7f, right panel) . Altogether, loss of function of Slp4 and Slac2b induces phenotypes that, in terms of exosome secretion as well as morphology and distribution of MVEs, highly resemble those observed in cells knocked down for Rab27a and Rab27b, respectively. These observations suggest that Slp4 mediates the function of Rab27a, while Slac2b is required for the function of Rab27b.
Consistent with this idea, in cells co-transfected with T7-tagged Slp4 or Slac2b and GFP-tagged Rab27a or Rab27b, Slp4 colocalized with Rab27a to doughnut-like structures containing CD63 (Fig. 8a, top panel) . In contrast, Slp4 and Rab27b labelled different CD63-positive structures (Fig. 8a, bottom panel) . The Rab27a-Slp4 interaction was also confirmed by the observation that the Slp4 protein level was decreased in Rab27a-knockdown cells (but not in Rab27b-knockdown cells; Fig. 8b ; Supplementary Information, Fig. S6d ), whereas the SYTL4 mRNA level was increased (Fig. 8c) , suggesting a stabilizing interaction of Rab27a and Slp4 proteins. Due to low expression level of endogenous Slac2b, which could not be detected by the available antibodies, and to poor expression of a T7-Slac2b construct in our cell line, we could neither determine its intracellular distribution nor its preferential association with Rab27b. Finally, co-silencing of Rab27a and Slp4 led to a similar phenotype as single silencing of each (that is, enlarged MVEs), whereas co-silencing of Rab27b and Slp4 induced mainly the perinuclear redistribution of MVEs typical in Rab27b-knockdown cells, thus confirming that Rab27b and Slp4 are not functionally associated ( Supplementary Information, Fig. S4 ).
These observations thus show that Rab27a and Slp4 function together in the MVE and exosome pathway of HeLa cells. By contrast, although silencing of Slac2b induces a phenocopy of Rab27b-knockdown cells, for technical reasons we could not demonstrate the functional interaction between these two proteins.
Discussion
Three major results are presented here. First, we set up an assay allowing medium-scale screens of the molecular machinery involved in exosome secretion. Second, using this assay, we identified several Rab family members, including Rab27a and Rab27b, that function in exosome secretion. Third, we found that Rab27a and Rab27b serve both common and different roles, most likely through the Slp4 and Slac2b effector proteins, respectively, in the intracellular trafficking of MVEs, leading to exosome secretion.
The identification of Rab GTPases that affect both the morphology and distribution of CD63-positive MVEs and exosome secretion confirms the endocytic origin of exosomes, which was proposed previously based on results from elegant electron microscopy studies 5, 15 . In addition, as reducing mRNA expression of RAB27 genes to less than 20% of the control induced > 50% reduction in exosome secretion, most secreted exosomes originate from a Rab27-dependent secretion event, probably due to fusion of late endocytic compartments with the plasma membrane. In addition to Rab27, three other Rabs related to the endocytic pathway were identified in this study as being potentially involved in exosome secretion: Rab9 and Rab5 participate in the trafficking of late and early endosomes, respectively 17, 28 , and Rab2, although generally described as allowing trafficking between the endoplasmic reticulum and Golgi apparatus, is phylogenetically closer to Rab4, Rab11 and Rab14 (ref. 29) , which are associated with the endocytic pathway. Surprisingly, other Rab GTPases associated with the endocytic system, Rab7 and Rab11, did not modify exosome secretion. These observations suggest that a specific subset of MVEs participates in the generation of exosomes, as recently proposed for dendritic cells 30 . Rab27a and Rab27b have been found previously to be involved in the regulated secretion of secretory granules (that is, compartments of Golgi origin) [31] [32] [33] and of lysosome-related organelles in mast cells 34 , platelets 35 and cytolytic T lymphocytes 36 . In this study, we found that Rab27a and Rab27b have a key role in exosome secretion by promoting the targeting of MVEs to the cell periphery and their docking at the plasma membrane.
Functional redundancy between Rab27a and Rab27b depends on the cell type and/or the secretory process studied 34, 35, 37 . Interestingly, we show here that in the HeLa cell line, Rab27a and Rab27b perform different and non-redundant tasks in the exosomal pathway.
The phenotype of MVEs induced by Rab27b silencing (inhibition of docking, clustering in the perinuclear area and high velocity movements along microtubules), is similar to the phenotype of secretory granules 31 and melanosomes 38, 39 induced by silencing myosin Va, a downstream effector of Rab27a, and suggests that Rab27b mediates the transfer of MVEs from microtubules to the actin-rich cortex and their retention at the cell periphery. In addition, the smaller size of MVEs observed by electron microscopy in Rab27b-knockdown cells suggests that Rab27b could participate in the transfer of membranes from the TGN to MVEs, as proposed previously 40 . In contrast, Rab27a silencing reduces docking of MVEs and increases their size. This could be due to lack of motor linkage, resulting in apparently enlarged compartments. Alternatively, either Rab27a is required for docking and vesicles fuse with each other instead of fusing with the plasma membrane when Rab27a is absent, or Rab27a prevents fusion of CD63-positive compartments with each other or with other vesicular intermediates, and its absence leads to the formation of enlarged compartments whose size physically impairs docking to the plasma membrane.
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In addition, we show here that silencing of the Rab27 effectors Slp4 and Slac2b phenocopies the silencing of Rab27a and Rab27b, respectively, and that Slp4 preferentially associates with Rab27a, rather than with Rab27b, and thus regulates the Rab27a-dependent docking event leading to exosome secretion in HeLa cells. The preferential interaction of Rab27b with Slac2b in HeLa cells could not be demonstrated here, although it has been previously demonstrated in vitro 41 . Finally, this work was performed using the HeLa model cell line: the physiological processes at work in HeLa cells may not be identical to those of other cell types. However, mouse dendritic cells deficient in both Rab27a and Rab27b secrete half the amount of exosomes that their wild-type counterparts do ( Supplementary Information, Fig. S5 ) and our preliminary data suggest that silencing of Rab27a in a mouse tumour cell line also leads to reduced exosome secretion (A. Bobrie, M.O. and C.T., unpublished data). Thus, the Rab27 subfamily is probably also important in exosome secretion by other cell types. Overall, the potential to specifically inhibit exosome secretion without affecting the regular secretory pathway of soluble proteins paves the way for the manipulation of exosome secretion in vivo, to eventually answer the long-standing question of the physiological functions of exosomes in vivo. 
METHODS
Methods
METHODS
Cells and reagents.
HeLa-CIITA cells 42 were stably transfected with pcDNA3 encoding the OVA cDNA fused to the signal peptide of MFG-E8/lactadherin 13 , and a subclone named B6H4 was selected. These cells were cultured in DMEM containing 4.5 g l -1 glucose (Invitrogen) 10% fetal calf serum (Abcys), 2 mM glutamine, 100 IU ml -1 penicillin, 100 μg ml -1 streptomycin, 300 μg ml -1 hygromycin B (Calbiochem) and 500 μg ml -1 geneticin (Invitrogen). Plasmids used for transient transfections (performed with Bio-Rad gene pulser II) 42 . 45) , mCherry-Rab27a generated by PCR from pcDNA3.1mcherry 46 and pEGFPC3-Rab27a, and cloned into pCMVMyc vector (A.N.H., unpublished data) 38 . Lentiviruses expressing shRNA were obtained from the RNAi consortium (TRC) and produced as described previously 47 . Sequences of the shRNA used for large scale cultures were: RAB27A, 5´-GCTGCCAATGGGACAAACATA-3´; RAB27B, CCCAAATTCATCACTACAGTA-3´; SYTL4, 5´-CCTCCCTTTACAT-GGAAAGAT-3´ and EXPH5, 5´-CCCAAACTAGAAGAAGTTCTT-3´.
Antibodies used for FACS analysis were: mouse anti-human CD63 (FC-5.01, Zymed) and goat anti-OVA (ICN) for coupling to beads; PE-conjugated anti-HLA-DR (L243, BD), anti-CD81 (BD) and rabbit anti-OVA (Sigma) coupled to Alexa488 according to the manufacturer's instructions (Pierce). Antibodes used for immunoblotting were: goat anti-Tsg101 (Santa Cruz); rat anti-Gp96 and anti -Hsc70 Cell culture supernatants were cleared by centrifugations at 300g (for 5 min) and 2,000g (for 20 min). Cleared supernatants (100 μl) were incubated with 20,000 anti-CD63-and 20,000 anti-OVA-coupled beads overnight at room temperature with 6,500 rpm horizontal shaking. Beads were washed twice in PBS-2% BSA and incubated with PE-anti-HLA-DR + PE-anti-CD81 and Alexa488-anti-OVA (all at a 1:100 dilution) for 30 min on ice. Beads were washed twice in annexin V buffer (BD Biosciences) and incubated with APC-conjugated annexin V (1:10) for 10 min. Beads were acquired on a FACSCalibur (BD) and data were analysed with FlowJo software (Tree Star). Threshold of negative staining was obtained with beads incubated with unconditioned medium, and for each culture condition, arbitrary units (AU) of exosome or OVA secretion were calculated as a percentage of positive beads × MFI (mean fluoresence intensity) of positive beads. To rule out detection of apoptotic blebs, a total of 50,000 cells either UV-irradiated or untreated were seeded in a 96-well plate. After 12 h incubation, exosome depleted-medium was added and 24 h later supernatants were incubated with anti-CD63-coated beads and analysed by FACS. Lentiviral infection and screening procedure. HeLa B6H4 cells were plated in 96-well round-bottom plates at 2,500 cells per well (day zero). At day 1, cells were infected with lentiviral vectors in the presence of 8 μg ml -1 polybrene and 5 μg ml -1 puromycin was added at day 2. Medium was replaced with exosome-depleted medium at day 4. Supernatants were collected 48 h later for OVA and exosome quantification, and the amount of live cells in each well was determined using Cell titer blue reagent viability assay (Promega). OVA and exosome secretions per well were normalized to the number of viable cells, and only wells containing at least 75,000 cells were analysed. In each experiment, the basal level of exosome or OVA secretion (control) was calculated as either AU of cells transduced with control scrambled shRNA, or mean of AU of one entire plate. A candidate gene was defined as a hit if two or more shRNAs modified AU of exosome secretion, in duplicate, by more than one standard deviation from the control. Results are presented as percent of AU of control.
Quantitative reverse transcription-PCR (qRT-PCR).
RNAs were isolated from each well at day 5 after lentiviral infection with the Qiagen RNeasy Mini Kit and 200 ng were reverse transcribed with AMV RT (Finnzymes). cDNA (1/10th) was used for each PCR reaction, performed with SYBRgreen (Thermo Scientific) on ABI PRISM 7900 real-time thermal cycler (Applied Biosystems). Primer sequences for each gene were either retrieved from Primer Bank (http://pga. mgh.harvard.edu/primerbank/) or designed using Primer3 (http://frodo.wi.mit. edu/cgi-bin/primer3/primer3_www.cgi). Cycle thresholds (Ct) were normalized to Ct of GAPDH and fold enrichments were calculated as compared with the values from control shRNA-transduced cells.
Exosome purification. Cells were cultured in 'exosome-depleted medium' (complete medium depleted of FCS-derived exosomes by overnight centrifugation at 100,000g) for 48 h and exosomes were purified by filtration on 0.22-μm pore filters, followed by ultracentrifugation at 100,000g as described previously 24 . In each exosome preparation, the concentration of total proteins was quantified by Bradford assay (BioRad).
Electron microscopy. Exosomes fixed in 2% paraformaldehyde were loaded on Formwar/carbon-coated electron microscopy grids. Samples were post-fixed in 1% glutaraldehyde, contrasted and embedded as described previously 5 . For immunolabelling, cells were fixed with 2% paraformaldehyde in 0.2 M phosphate buffer at pH 7.4 and processed for ultrathin sectioning and immunolabelling with the indicated antibodies and protein A coupled to 10-or 15-nm gold particles (Cell Microscopy Center) as described previously 5 . Sections were observed at 80kV with a CM120 Twin Philipps electron microscope (FEI Company) and digital acquisitions were made with a numeric camera (Keen View; Soft Imaging system). Quantification of the surface of MVBs was performed on at least 40 CD63-positive multivesicular compartments present in randomly taken pictures, analysed using iTelectron microscopy software (Olympus).
Immunoblotting. Cells were lysed in 50 mM Tris at pH 7.5, 0.3 M NaCl, 0.5% Triton X-100 and 0.1% sodium azide, with a cocktail of antiproteases (Roche), and cleared from nuclei by centrifugation at 15,000g for 5 min. Protein extracts were separated on 4-12% SDS-PAGE, blotted on Immobilon (Millipore), and HRP-conjugated secondary antibodies were revealed using chemoluminescence substrate (Roche). Images were acquired using Chemidoc XRS (BioRad), intensity of the bands was quantified using QuantityOne software (Biorad) and results were expressed as a ratio to control cells.
Flow cytometry. For surface labelling, cells were stained with antibodies diluted in PBS-0.5% BSA on ice. For intracellular + surface staining, cells fixed with 1% paraformaldehyde were quenched with PBS-0.1 M glycine, permeabilized using PermWash reagent (BD), and stained with antibodies diluted in permeabilization buffer. Cells were acquired on a FACScalibur and analysed using FlowJo software.
Immunofluorescence microscopy. Cells (1 × 10 5 ) were seeded on glass coverslips for 18 h, fixed in 4% paraformaldehyde, quenched with 0.1 M glycine, permeabilized in PBS-0.2% BSA-0.05% saponin, and incubated with primary and secondary fluorescent antibodies. The coverslips mounted with Fluoromount-G (Southern Biotechnology Associates) were examined under a motorized upright wide-field microscope (Leica DMRA2) equipped for image deconvolution. Acquisition was performed using a ×100 objective (PL APO HCX, 1.4 NA) and a high-sensitive cooled interlined CCD camera (Roper CoolSnap HQ). z-positioning was accomplished by a piezo-electric motor (LVDT, Physik Instrument) and a z-series of images was taken (an image every 0.2 μm). Images were acquired with Metamorph Software. Vesicle sizes were calculated with the Multidimensional Image Analysis (MIA) interface based on wavelet decomposition 48 , running under MetaMorph (Universal Imaging Corporation). Briefly, fluorescent objects corresponding to MVEs were detected as fluctuations that were 20-fold larger than the noise. The watershed function was routinely applied to precisely detect individual structures in dense regions. The diameter of each structure was calculated from the sum of pixels assuming a spherical shape. Alternatively, images were acquired with Zeiss confocal microscope (LSM Axivert 720) using 6 3 × 1.4 NA oil immersion objective. Image acquisition and analysis were performed in the PICT IbiSA Imaging Facility (Curie Institute). Brightness and contrast of the images shown DOI: 10.1038/ncb2000 in Figs 4b, 5a, 7f and 8a were adjusted for better visualization according to Nature Cell Biology guidelines for the presentation of digital data.
Quantification of asymmetrical distribution of CD63-positive vesicles was performed manually in a double-blind setting. Asymmetry was defined as a concentration of the CD63-staining in one side of the nucleus (covering less than 50% of the nucleus diameter).
Total internal reflection fluorescence (TIRF) microscopy. B6H4 cells stably expressing shRNA were transfected with a GFP-CD63-encoding plasmid 36 h before analysis by TIRF microscopy. TIRF imaging was performed on a custom setup as described previously 26 . The penetration depth (δ) of the evanescent field used to excite the fluorophore was set to 150 nm. Frames were acquired at 10 Hz in stacks of 450 images with an exposure time of 100 ms. One pixel corresponds to 107.5 nm. The density of GFP-CD63 structures was evaluated using MIA software 48 . The quantification was performed on regions devoid of TGNlike labelling and expressed as the number of observed CD63-positive structures divided by the size of the cell footprint. From stacks of images, two-dimensional (x, y) trajectories were obtained by single particle tracking using MIA software. Mean square displacement (MSD) in the x, y plane was calculated as described previously 25, 49 . The diffusion coefficient D xy was then calculated as D xy = s/4, s being the slope of the linear fit of the first 15 points of the MSD curve. To measure D xy variations along a given trajectory, a rolling analysis window of 2.5 s was used as described previously 25 . Using this method, a D xy value was attributed to each point of the trajectory. Immobilization periods correspond to portions of trajectories during which D xy < 3 × 10 -4 μm 2 s -1
. Survival curves for immobilization times (that is, the number of events per trajectory lasting at least the indicated immobilization time) were computed for each cell and averaged over the different cells. The best fit for the curves was obtained with the sum of 2 exponentials,
, using SigmaPlot (Systat Software). N 1 and N 2 represent the abundance of each component and τ 1 and τ 2 , their time constants. Portions of trajectories showing directed motion were detected by inspection of x vs t and y vs t plots and selected using locally written routines (MatLab, The MathWorks). Frame-to-frame rates of movement were calculated and averaged over each period of directed motion.
Statistical analyses. Data were analysed using GraphPad Prism (GraphPad Software). Normality of the data was tested using the Kolmogorov-Smirnov test. Based on the normality test, either one-way ANOVA followed by Tukey's post test 
